Dashboard
Manage Tickers

ELEV


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-elevation-oncology-maintains-6-price-target
HC Wainwright & Co. Reiterates Buy on Elev...
08/07/2024 20:13:11

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Elevation Oncology (NASDAQ:ELEV) with a Buy and maintains ...

sp-500-surges-over-2-caterpillar-earnings-beat-estimates
S&P 500 Surges Over 2%; Caterpillar Earnin...
08/06/2024 18:39:01

why-is-penny-stock-elevation-oncology-trading-lower-on-tuesday
Why Is Penny Stock Elevation Oncology Trad...
08/06/2024 16:36:44

Elevation Oncology shares dropped after initial data from the Phase 1 trial of EO-3021 showed a 42.8% objective response rate i...

crude-oil-moves-higher-yum-brands-posts-upbeat-earnings
Crude Oil Moves Higher; Yum! Brands Posts ...
08/06/2024 16:05:26

dow-jumps-over-300-points-us-trade-gap-narrows-in-june
Dow Jumps Over 300 Points; US Trade Gap Na...
08/06/2024 14:22:05

elevation-oncology-expects-its-existing-cash-cash-equivalents-and-marketable-securities-as-of-june-30-2024-of-1108m-to-be-sufficient-to-fund-its-current-operations-into-2026
Elevation Oncology Expects Its Existing Ca...
08/06/2024 11:25:19

elevation-oncology-q2-2024-gaap-eps-018-beats-022-estimate
Elevation Oncology Q2 2024 GAAP EPS $(0.18...
08/06/2024 11:24:30

elevation-oncology-reports-initial-data-from-dose-escalation-portion-of-ongoing-phase-1-clinical-trial-of-eo-3021-428-confirmed-orr-observed-in-claudin-182-enriched-subset-of-gastric-and-gej-cancer
Elevation Oncology Reports Initial Data Fr...
08/06/2024 11:18:05

"We are encouraged to see the benefits of EO-3021's site-specific conjugation translate clinically, with minimal MMAE-a...

genedx-leads-russell-2000-this-year-as-it-shifts-to-more-comprehensive-genetic-testing-corrected
GeneDx Leads Russell 2000 This Year As It ...
08/02/2024 18:06:16

GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and r...

genedx-leads-russell-2000-this-year-as-it-shifts-to-more-comprehensive-genetic-testing-corrected
GeneDx Leads Russell 2000 This Year As It ...
08/02/2024 18:06:16

GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and r...

jmp-securities-reiterates-market-outperform-on-elevation-oncology-maintains-7-price-target
JMP Securities Reiterates Market Outperfor...
07/15/2024 13:46:46

JMP Securities analyst Silvan Tuerkcan reiterates Elevation Oncology (NASDAQ:ELEV) with a Market Outperform and maintains $7...

jmp-securities-reiterates-market-outperform-on-elevation-oncology-maintains-7-price-target
JMP Securities Reiterates Market Outperfor...
06/28/2024 14:39:23

JMP Securities analyst Silvan Tuerkcan reiterates Elevation Oncology (NASDAQ:ELEV) with a Market Outperform and maintains $7...

elevation-oncology-plans-to-expand-its-ongoing-phase-1-trial-to-include-two-combination-cohorts-evaluating-eo-3021-for-advanced-gastric-or-gastroesophageal-junction-cancer-the-company-expects-to-initiate-dosing-in-combination-portion-by-year-end-2024
Elevation Oncology Plans To Expand Its Ong...
06/27/2024 11:32:22

Following recently signed clinical supply agreements with Eli Lilly and Company (Lilly) and GSK, respectively, Elevation Oncolo...

piper-sandler-initiates-coverage-on-elevation-oncology-with-overweight-rating-announces-price-target-of-10
Piper Sandler Initiates Coverage On Elevat...
05/31/2024 09:56:27

Piper Sandler analyst Biren Amin initiates coverage on Elevation Oncology (NASDAQ:ELEV) with a Overweight rating and announc...

stephens--co-initiates-coverage-on-elevation-oncology-with-overweight-rating-announces-price-target-of-8
Stephens & Co. Initiates Coverage On Eleva...
05/14/2024 10:13:41

Stephens & Co. analyst Sudan Loganathan initiates coverage on Elevation Oncology (NASDAQ:ELEV) with a Overweight rating ...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
05/13/2024 20:31:07

wedbush-reiterates-outperform-on-elevation-oncology-maintains-8-price-target
Wedbush Reiterates Outperform on Elevation...
05/03/2024 13:38:58

Wedbush analyst Robert Driscoll reiterates Elevation Oncology (NASDAQ:ELEV) with a Outperform and maintains $8 price target.

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
05/02/2024 16:31:17

elevation-oncology-shares-are-trading-lower-after-the-company-reported-worse-than-expected-q1-gaap-eps-results
Elevation Oncology shares are trading lowe...
05/02/2024 16:00:16

elevation-oncology-says-cash-cash-equivalents-and-marketable-securities-of-1041m-as-of-march-31-2024-plus-145m-in-net-proceeds-raised-under-its-atm-facility-subsequent-to-q1-of-2024-to-be-sufficient-to-fund-its-current-operations-into-2026
Elevation Oncology Says Cash, Cash Equival...
05/02/2024 12:26:15

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION